Yeah, it is pretty amazing to see a 1/2 billion dollar market cap on a non revenue company. What is even more amazing to me is that we are only at 6 million. To me ENDV holds even greater potential than Pulse. The diversity in the number of ailments that are being addressed with this therapy is very broad and represents a huge potential market when they are combined. Once results start coming I think we are in for a real ride here.
News 
Market Data 
Discover 
